Time-kill studies with a ceftazidime-treated mixed culture consisting of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus

Engineering in Life Sciences

Volumn 12, Issue 2, 2012, Pages 188-197

  Riedele, Christian ^a   Reichl, Udo ^b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cell lysis; Mixed population; QT RFLP; Single cell analysis; Time kill curve

Indexed keywords

CELL LYSIS; MIXED POPULATION; QT-RFLP; SINGLECELL ANALYSIS; TIME-KILL CURVE;

BACTERIA;

CELL CULTURE;

CEFTAZIDIME; GLUCONIC ACID; GLUTAMIC ACID; GLUTAMINE;

BACTERIUM; DRUG; METABOLITE; REGROWTH; SUBSTRATE; WASTEWATER;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; FUNGUS CULTURE; FUNGUS GROWTH; MICROBIOLOGICAL PARAMETERS; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STAPHYLOCOCCUS AUREUS; TIME KILL STUDY;

BURKHOLDERIA CEPACIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84860282584     PISSN: 16180240     EISSN: 16182863     Source Type: Journal    
DOI: 10.1002/elsc.201100147     Document Type: Article

References (25)

1. Yano, Y., Oguma, T., Nagata, H., Sasaki, S., Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics. J. Pharm. Sci. 1998, 87, 1177-1183.
2. Barger, A., Fuhst, C., Wiedemann, B., Pharmacological indices in antibiotic therapy. J. Antimicrob. Chemother. 2003, 52, 893-898.
3. Gloede, J., Scheerans, C., Derendorf, H., Kloft, C., In vitro pharmacodynamic models to determine the effect of antibacterial drugs. J. Antimicrob. Chemother. 65, 2010, 186-201.
4. Riedele, C., Reichl, U., Interspecies effects in a ceftazidime-treated mixed culture of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus: analysis at the single-species level. J. Antimicrob. Chemother. 2011, 66, 138-145.
5. Washington, J. A., Jones, R. N., Gerlach, E. H., Murray, P. R. et al., Multicenter comparison of in-vitro activities of Fk-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrob. Agents Chemother. 1993, 37, 1696-1700.
6. Schmidt, J. K., Konig, B., Reichl, U., Characterization of a three bacteria mixed culture in a chemostat: Evaluation and application of a quantitative terminal-restriction fragment length polymorphism (T-RFLP) analysis for absolute and species specific cell enumeration. Biotechnol. Bioeng. 2007, 96, 738-756.
7. Trotha, R., Reichl, U., Thies, F. L., Sperling, D. et al., Adaption of a fragment analysis technique to an automated high-throughput multicapillary electrophoresis device for the precise qualitative and quantitative characterization of microbial communities. Electrophoresis 2002, 23, 1070-1079.
8. Sevillano, D., Aguilar, L., Alou, L., Gimenez, M. J. et al., Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria. Int. J. Antimicrob. Agents 2010, 36, 137-144.
9. Katsube, T., Yano, Y., Yamano, Y., Munekage, T. et al., Pharmacokinetic-pharmacodynamic modeling and simulation for bactericidal effect in an in vitro dynamic model. J. Pharma. Sci. 2008, 97, 4108-4117.
10. Soriano, F., Ponte, M. C., Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp in pure and mixed cultures. Antimicrob. Agents Chemother. 1984, 26, 39-41.
11. Schaumann, R., Goldstein, E. J. C., Forberg, J., Rodloff, A. C., Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures. J. Med. Microbiol. 2005, 54, 749-753.
12. Thrupp, L. D., Antibiotics in laboratory medicine, in: Lorian, V. (Ed.), Antibiotics in Laboratory Medicine, Wiliams & Wilkins, Baltimore /London 1980, 73-113.
13. Sachs, L., Hedderich, J., Angewandte Statistik, Springer, Heidelberg, Germany 2009.
14. Li, Z. S., Clarke, A. J., Beveridge, T. J., Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria. J. Bacteriol. 1998, 180, 5478-5483.
15. Allan, N. D., Kooi, C., Sokol, P. A., Beveridge, T. J., Putative virulence factors are released in association with membrane vesicles from Burkholderia cepacia. Can. J. Microbiol. 2003, 49, 613-624.
16. Lessie, T. G., Phibbs, P. V., Alternative pathways of carbohydrate utilization in Pseudomonads. Annu. Rev. Microbiol. 1984, 38, 359-387.
17. Tlemcani, L. L., Corroler, D., Barillier, D., Mosrati, R., Physiological states and energetic adaptation during growth of Pseudomonas putida mt-2 on glucose. Arch. Microbiol. 2008, 190, 141-150.
18. Swanson, B. L., Hager, P., Phibbs, P., Ochsner, U. et al., Characterization of the 2-ketogluconate utilization operon in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 2000, 37, 561-573.
19. Vicente, M., Canovas, J. L., Regulation of glycolytic enzymes in Pseudomonas putida. Arch. Microbiol. 1973, 93, 53-64.
20. Turnidge, J. D., The pharmacodynamics of beta-lactams. Clin. Infect. Dis. 1998, 27, 10-22.
21. Desai, M., Buhler, T., Weller, P. H., Brown, M. R. W., Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob. Chemother. 1998, 42, 153-160.
22. Wiedemann, B., Pfeifle, D., Wiegand, I., Janas, E., beta-lactamase induction and cell wall recycling in gram-negative bacteria. Drug Resist. Updat. 1998, 1, 223-226.
23. Frere, J. M., Joris, B., Crine, M., Martin, H. H., Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria-II. Non-steady-state treatment and progress curves. Biochem. Pharmacol. 1989, 38, 1427-1433.
24. Bulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A. et al., Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2009, 53, 46-56.
25. Dalhoff, A., Cullmann, W., Specificity of beta-lactamase induction in Pseudomonas-aeruginosa. J. Antimicrob. Chemother. 1984, 14, 349-357.